These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2006-003657-24||A PHASE II MULTICENTER NON-RANDOMIZED STUDY TO ASSESS SAFETY, TOXICITY AND CLINICAL ACTIVITY OF THE ASSOCIATION OF BORTEZOMID VELCADE WITH RITUXIMAB IN RELAPSED/REFRACTORY INDOLENT NON FOLLICULAR AN...||bad-data|
|Completed, but no date Terminated||2007-003539-22||Two repeated doses of Yttrium-90 labeled Ibritumomab-Tiuxetan (Zevalin) as salvage treatment for patients with relapsed or refractory aggressive B-cell lymphoma: a phase II study.||bad-data|
|Ongoing||2007-003560-21||Prospective multicenter dose finding phase II pilot trial to evaluate efficacy and safety of treatment with Lenalidomide puls R-CHOP21 (LR-CHOP21) for elderly patients with untreated Diffuse Large B-C...||not-yet-due|